Squarepoint’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-5,633
| Closed | -$199K | – | 2911 |
|
|
2022
Q4 | $199K | Buy |
+5,633
| New | +$199K | ﹤0.01% | 1893 |
|
|
2021
Q1 | – | Sell |
-1,846
| Closed | -$681K | – | 3163 |
|
|
2020
Q4 | $681K | Buy |
1,846
+1,388
| +303% | +$512K | 0.01% | 1294 |
|
|
2020
Q3 | $112K | Buy |
+458
| New | +$112K | ﹤0.01% | 2107 |
|
|
2020
Q2 | – | Sell |
-1,390
| Closed | -$284K | – | 2511 |
|
|
2020
Q1 | $284K | Sell |
1,390
-2,784
| -67% | -$569K | 0.01% | 1313 |
|
|
2019
Q4 | $1.87M | Buy |
4,174
+266
| +7% | +$119K | 0.01% | 923 |
|
|
2019
Q3 | $1.2M | Sell |
3,908
-178
| -4% | -$54.7K | 0.01% | 1075 |
|
|
2019
Q2 | $1.3M | Buy |
4,086
+2,448
| +149% | +$778K | 0.01% | 1090 |
|
|
2019
Q1 | $687K | Buy |
1,638
+416
| +34% | +$174K | 0.01% | 1296 |
|
|
2018
Q4 | $372K | Buy |
1,222
+882
| +259% | +$268K | ﹤0.01% | 1388 |
|
|
2018
Q3 | $122K | Buy |
+340
| New | +$122K | ﹤0.01% | 1850 |
|